Bioceres Crop Solutions Corp. (BIOX)
NASDAQ: BIOX · Real-Time Price · USD
0.23415
+0.0217 (10.19%)
At close: Nov 6, 2026, 4:00 PM EST
0.2384
+0.0043 (1.82%)
After-hours: Nov 6, 2026, 6:21 PM EST

Company Description

Bioceres Crop Solutions Corp., together with its subsidiaries, develops and commercializes crop productivity solutions in Argentina, Brazil, the rest of Latin America, and internationally.

It operates through Seed and Integrated Products, Crop Protection, and Crop Nutrition segments. The company offers biological crop nutrition products comprising seed inoculants under the Rizoliq and UHC brands, biofertilizers, and biostimulants; biocontrol products, including bionematicides, biofungicides, and bioinsecticides; crop nutrition and crop protection products, such as micro-beaded fertilizers and adjuvants; and seed germplasms, GMO and non-GMO traits, and ready-to-use seed treatment pack solutions for healthier and higher yielding crops.

It also provides fungicide products under the Rizoderma brand; Rizofos for foliar applications; therapies, herbicides, and baits; and bio-inductors, crop health products, and biological and micro granulated fertilizers.

In addition, the company licenses its HB4 seed trait for drought tolerance in wheat and soybean seeds.

It sells its products to blue-chip companies and industry leaders, large distributors, co-ops, dealers, large farmers, and individual growers through distributors and dealers.

The company was founded in 2001 and is headquartered in Rosario, Argentina.

Bioceres Crop Solutions Corp.
Bioceres Crop Solutions logo
CountryArgentina
Founded2001
IndustryAgricultural Inputs
SectorMaterials
Employees562
CEOFederico Trucco

Contact Details

Address:
Ocampo 210 bis, Predio CCT
Rosario, 2000
Argentina
Phone54 34 1486 1100
Websiteinvestors.biocerescrops.com

Stock Details

Ticker SymbolBIOX
ExchangeNASDAQ
Fiscal YearJuly - June
Reporting CurrencyUSD
CIK Code0001769484
CUSIP NumberG1117K114
ISIN NumberKYG1117K1141
SIC Code2870

Key Executives

NamePosition
Dr. Federico Trucco Ph.D.Chief Executive Officer and Executive Director
Jose A. RoqueGeneral Counsel and Chief Compliance Officer
Alejandro VillafanePrincipal Accounting Officer
Maria Paula SavantiHead of Investor Relations

Latest SEC Filings

DateTypeTitle
Oct 30, 202620-FAnnual and transition report of foreign private issuers
Sep 21, 20266-KReport of foreign issuer
Sep 16, 20266-KReport of foreign issuer
Jul 7, 2026SCHEDULE 13D/AFiling
Jun 22, 20266-KReport of foreign issuer
Jun 1, 2026SCHEDULE 13D/AFiling
Jun 1, 20266-KReport of foreign issuer
May 12, 20266-KReport of foreign issuer
Apr 28, 2026SCHEDULE 13D/AFiling
Mar 24, 2026SCHEDULE 13D/AFiling